These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 26515168)

  • 1. [Pathological and metabolic bone diseases: Clinical importance for fracture treatment].
    Oheim R
    Unfallchirurg; 2015 Dec; 118(12):1007-16. PubMed ID: 26515168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Medication and bone metabolism: Clinical importance for fracture treatment].
    Barvencik F
    Unfallchirurg; 2015 Dec; 118(12):1017-24. PubMed ID: 26573290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe hypocalcemia associated with zoledronic acid treatment in a patient with a risk of fracture due to drug-induced osteopenia.
    Cure E; Yuce S; Cure MC
    Minerva Endocrinol; 2013 Jun; 38(2):217-8. PubMed ID: 23732377
    [No Abstract]   [Full Text] [Related]  

  • 4. [Paget's disease: case report].
    Wegierska M; Ignaczak P; Zalewska J; Jeka S
    Ann Acad Med Stetin; 2011; 57(3):64-9; discussion 69. PubMed ID: 23383549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone mineral density loss, osteoporosis, and fractures in HIV.
    Labarga P
    AIDS Rev; 2013; 15(3):189-90. PubMed ID: 24002203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Low Bone Density or Osteoporosis to Prevent Fracture.
    Ann Intern Med; 2017 Jun; 166(11):. PubMed ID: 28492833
    [No Abstract]   [Full Text] [Related]  

  • 7. Failure of teriparatide in treatment of bone complications of adult hypophosphatasia.
    Laroche M
    Calcif Tissue Int; 2012 Mar; 90(3):250. PubMed ID: 22218563
    [No Abstract]   [Full Text] [Related]  

  • 8. [Editor's commentary].
    Tóth M
    Orv Hetil; 2011 Aug; 152(33):1303. PubMed ID: 21824856
    [No Abstract]   [Full Text] [Related]  

  • 9. Alendronate in combination with calcium and vitamin D prevents bone loss after orthotopic liver transplantation: a prospective single-center study.
    Millonig G; Graziadei IW; Eichler D; Pfeiffer KP; Finkenstedt G; Muehllechner P; Koenigsrainer A; Margreiter R; Vogel W
    Liver Transpl; 2005 Aug; 11(8):960-6. PubMed ID: 16035083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Monostotic patellar Paget's disease].
    Hernández-Pascual C; Villanueva-Martínez M; Ríos-Luna A; Benito-del Carmen F; Castelorio R
    Acta Ortop Mex; 2010; 24(1):14-7. PubMed ID: 20377059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe hypocalcemia following bisphosphonate treatment in a patient with Paget's disease of bone.
    Whitson HE; Lobaugh B; Lyles KW
    Bone; 2006 Oct; 39(4):954-8. PubMed ID: 16769264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoporotic compression fractures of the spine; current options and considerations for treatment.
    Kim DH; Vaccaro AR
    Spine J; 2006; 6(5):479-87. PubMed ID: 16934715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisphosphonates and glucocorticoid-induced osteoporosis: cons.
    Lems WF; Saag K
    Endocrine; 2015 Aug; 49(3):628-34. PubMed ID: 26041376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of postmenopausal osteoporosis and the prevention of fractures.
    Gambacciani M; Levancini M
    Panminerva Med; 2014 Jun; 56(2):115-31. PubMed ID: 24942322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacotherapeutic management of osteoprosis and osteopenia.
    Alexander IM
    Nurse Pract; 2009 Jun; 34(6):30-40; quiz 41. PubMed ID: 19474629
    [No Abstract]   [Full Text] [Related]  

  • 16. Osteoporosis: the evolution of a diagnosis.
    Lorentzon M; Cummings SR
    J Intern Med; 2015 Jun; 277(6):650-61. PubMed ID: 25832448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paget's disease of bone and calcium homeostasis: focus on bisphosphonate treatment.
    Polyzos SA; Anastasilakis AD; Makras P; Terpos E
    Exp Clin Endocrinol Diabetes; 2011 Oct; 119(9):519-24. PubMed ID: 21811962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of bone loss and vertebral fractures in patients with chronic epilepsy--antiepileptic drug and osteoporosis prevention trial.
    Lazzari AA; Dussault PM; Thakore-James M; Gagnon D; Baker E; Davis SA; Houranieh AM
    Epilepsia; 2013 Nov; 54(11):1997-2004. PubMed ID: 24010637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Metabolic bone diseases: benefits and risks of the treatment].
    Rizzoli R
    Rev Med Suisse; 2009 Jun; 5(207):1299-300. PubMed ID: 19626928
    [No Abstract]   [Full Text] [Related]  

  • 20. A review of Paget's disease of bone with a focus on the efficacy and safety of zoledronic acid 5 mg.
    Abelson A
    Curr Med Res Opin; 2008 Mar; 24(3):695-705. PubMed ID: 18226324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.